Pine River Capital Management’s ResMed RMD Stock Holding History

Pine River Capital Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-8,600	Closed	-$485K	–	715
2015 Q2	$485K	Buy	+8,600	New	+$543K	0.01%	589
2014 Q4	–	Sell	-7,179	Closed	-$354K	–	922
2014 Q3	$354K	Buy	+7,179	New	+$366K	﹤0.01%	816

Other funds holding RMD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Pine River Capital Management's RMD Position: Q3 2015 in Review

Pine River Capital Management sold out of ResMed (RMD) in Q3 2015, closing a stake of 8,600 shares — an estimated $485K sold.

Pine River Capital Management first reported a position in RMD in Q3 2014 and held it in 2 quarters. The position peaked at $485K in Q2 2015. 313 funds tracked by Wall St. Rank hold RMD as of Q3 2015.

Pine River Capital Management reported no remaining ResMed position as of Q3 2015 after selling out during the quarter.
Pine River Capital Management sold 8,600 ResMed shares in Q3 2015, an estimated $485K.
Pine River Capital Management first reported a position in ResMed in Q3 2014 and held it in 2 quarters.
Pine River Capital Management's ResMed position peaked at $485K in Q2 2015.
313 funds tracked by Wall St. Rank held ResMed as of Q3 2015.

Based on Pine River Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.